Allowing Medicare to cover popular weight loss drugs such as Wegovy and Zepbound could increase federal spending by billions of dollars, according to a new report by the Congressional Budget Office (CBO). Suggested Reading Honda recalls 2 million vehicles with a steering bug A Turkish Airlines pilot died mid-flight, forcing an emergency landing in New York McDonald's is joining the FTC in going after an alleged meat monopoly The next Nvidia? Data center stocks could be a goldmine, strategist

Tag-uri: Honda